Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 2/20 | 0.42 |
| ▸ | HTR1A | P08908 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9276947 | 0.89 | HTR1A (0.43) | PRCPHTR1A | |
| SCHEMBL4322788 | 0.80 | MEN1 (0.39) | — | |
| SCHEMBL9286439 | 0.77 | PRCP (0.37) | PRCPHTR1A | |
| SCHEMBL11038501 | 0.77 | SCN1A (0.46) | PRCPCHRM2 | |
| SCHEMBL7246918 | 0.75 | CARM1 (0.40) | ACHE | |
| SCHEMBL4341158 | 0.74 | PRCP (0.48) | PRCPHTR1AALDH1A1 | |
| SCHEMBL1751084 | 0.74 | HRH3 (0.40) | ALDH1A1DRD3 | |
| SCHEMBL7398553 | 0.73 | KCNH2 (0.43) | KCNH2 | |
| SCHEMBL11170273 | 0.73 | CHRNB4 (0.46) | KCNH2 | |
| Hydrochloric Acid SCHEMBL7398909 | 0.72 | KCNH2 (0.42) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-6211839-A | — | — | None | — | — | JP | disclosed |
| US-20060257852-A1 | Severe acute respiratory syndrome coronavirus | CHIRON CORPORATION (US) | 2006-11-16 | — | — | US | disclosed |
| CN-1829736-A | severe acute respiratory syndrome coronavirus | CHIRON CORP (US) | 2006-09-06 | — | — | CN | disclosed |
| EP-0605031-B1 | Phenoxy- and phenoxyalkyl-piperidines as antiviral agents | SANOFI SA (FR) | 1997-07-16 | — | — | EP | disclosed |
| US-5364865-A | Phenoxy- and phenoxyalkyl-piperidines as antiviral agents | STERLING WINTHROP INC. (US) | 1994-11-15 | — | — | US | disclosed |
| JP-H06211839-A | PHENOXY-AND PHENOXYALKYL-PIPERIDINES AS ANTIVIRAL AGENTS | STERLING WINTHROP INC | 1994-08-02 | — | — | JP | disclosed |
| EP-0605031-A1 | Phenoxy- and phenoxyalkyl-piperidines as antiviral agents | STERLING WINTHROP INC. (US) | 1994-07-06 | — | — | EP | disclosed |
| EP-0103252-A2 | Aryloxyalkyl amines, process for their preparation and their use in combating unwanted plant growth | BASF Aktiengesellschaft (DE) | 1984-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060257852-A1 | Severe acute respiratory syndrome coronavirus | SARS1, ACE2, ACE | PRCP 713/4885HTR1A 3788/4885ALDH1A1 4337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.